MedPath
NMPA Approval

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58)Vaccine

国药准字SJ20215001

January 5, 2024

S20180008

Drug Information

九价人乳头瘤病毒疫苗(酿酒酵母)

佳达修9

注射剂

0.5mL/瓶(西林瓶)

生物制品

January 5, 2024

March 30, 2028

Company Information

Applicant Company

Merck, Inc.

126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ 07065, US

Manufacturing Company

msd ireland

Dublin Road,Carlow Co., Carlow, Ireland

© Copyright 2025. All Rights Reserved by MedPath